Login to Your Account

ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

By Jennifer Boggs

Wednesday, March 1, 2006
Though it’s only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription